BACKGROUND: The antibody reactivity against Epstein-Barr nuclear antigen-1 (EBNA-1), and 25-hydroxyvitamin D (25(OH)D) status have been associated with multiple sclerosis (MS) risk. Interaction between these two factors has been proposed. OBJECTIVES: The objective of this paper is to examine the association between antibody reactivity against EBNA-1 and five EBNA-1 domains, and the risk of MS, and to examine if these antibodies and 25(OH)D status interact regarding MS risk in prospectively collected blood samples. METHODS: Antibody reactivity and 25(OH)D levels were measured using ELISAs in n = 192 MS cases and n = 384 matched controls. The risk of MS was analysed using matched logistic regression. Interaction on the additive scale was assessed. RESULTS: The risk of MS increased across tertiles of antibody reactivity against EBNA-1, domain EBNA-1(402-502), and domain EBNA-1(385-420); p trends < 0.001. In young individuals (below median age at sampling, < 26.4 years), these associations were stronger, and 25(OH)D levels correlated inversely to antibody reactivity against EBNA-1 and the EBNA-1 domains. No statistical interaction was found. CONCLUSIONS: We confirm that increased antibody reactivity against EBNA-1 is a risk factor of MS. 25(OH)D status might influence the immune response towards Epstein-Barr virus in young subjects, and thereby modulate MS risk.
BACKGROUND: The antibody reactivity against Epstein-Barr nuclear antigen-1 (EBNA-1), and 25-hydroxyvitamin D (25(OH)D) status have been associated with multiple sclerosis (MS) risk. Interaction between these two factors has been proposed. OBJECTIVES: The objective of this paper is to examine the association between antibody reactivity against EBNA-1 and five EBNA-1 domains, and the risk of MS, and to examine if these antibodies and 25(OH)D status interact regarding MS risk in prospectively collected blood samples. METHODS: Antibody reactivity and 25(OH)D levels were measured using ELISAs in n = 192 MS cases and n = 384 matched controls. The risk of MS was analysed using matched logistic regression. Interaction on the additive scale was assessed. RESULTS: The risk of MS increased across tertiles of antibody reactivity against EBNA-1, domain EBNA-1(402-502), and domain EBNA-1(385-420); p trends < 0.001. In young individuals (below median age at sampling, < 26.4 years), these associations were stronger, and 25(OH)D levels correlated inversely to antibody reactivity against EBNA-1 and the EBNA-1 domains. No statistical interaction was found. CONCLUSIONS: We confirm that increased antibody reactivity against EBNA-1 is a risk factor of MS. 25(OH)D status might influence the immune response towards Epstein-Barr virus in young subjects, and thereby modulate MS risk.
Entities:
Keywords:
Epstein-Barr Nuclear Antigen-1 (EBNA-1); Epstein-Barr virus (EBV); Multiple sclerosis; case-control study; risk factors in epidemiology; vitamin D (25(OH)D)
Authors: Tobias V Lanz; R Camille Brewer; Peggy P Ho; Jae-Seung Moon; Kevin M Jude; Daniel Fernandez; Ricardo A Fernandes; Alejandro M Gomez; Gabriel-Stefan Nadj; Christopher M Bartley; Ryan D Schubert; Isobel A Hawes; Sara E Vazquez; Manasi Iyer; J Bradley Zuchero; Bianca Teegen; Jeffrey E Dunn; Christopher B Lock; Lucas B Kipp; Victoria C Cotham; Beatrix M Ueberheide; Blake T Aftab; Mark S Anderson; Joseph L DeRisi; Michael R Wilson; Rachael J M Bashford-Rogers; Michael Platten; K Christopher Garcia; Lawrence Steinman; William H Robinson Journal: Nature Date: 2022-01-24 Impact factor: 69.504
Authors: Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl Journal: Mol Cell Proteomics Date: 2016-02-01 Impact factor: 5.911
Authors: Ali Afrasiabi; Grant P Parnell; Nicole Fewings; Stephen D Schibeci; Monica A Basuki; Ramya Chandramohan; Yuan Zhou; Bruce Taylor; David A Brown; Sanjay Swaminathan; Fiona C McKay; Graeme J Stewart; David R Booth Journal: Genome Med Date: 2019-04-30 Impact factor: 11.117